Ignite Creation Date:
2024-07-17 @ 11:05 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06467500
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-06-16
Brief Title:
A Prospective Open-label Single-center Single-arm Phase II Clinical Study of Cadonilimab AK104 Combined With Monotherapy Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer With Negative Driver Genes and Failed Immunotherapy
Sponsor:
Xin-Hua Xu
Organization:
China Three Gorges University Yichang China
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-16
First Submit QC Date:
None
Study First Post Date:
2024-06-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-16
Last Update Post Date:
2024-06-21
Last Update Post Date Type:
ACTUAL